BINDOLI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 1.005
EU - Europa 208
AS - Asia 99
OC - Oceania 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.317
Nazione #
US - Stati Uniti d'America 1.005
IT - Italia 137
CN - Cina 39
SG - Singapore 33
SE - Svezia 21
FI - Finlandia 17
VN - Vietnam 14
IN - India 12
GB - Regno Unito 9
DE - Germania 6
FR - Francia 6
AU - Australia 2
CH - Svizzera 2
NL - Olanda 2
UA - Ucraina 2
BR - Brasile 1
CL - Cile 1
ES - Italia 1
EU - Europa 1
IE - Irlanda 1
IR - Iran 1
RO - Romania 1
RS - Serbia 1
RU - Federazione Russa 1
SI - Slovenia 1
Totale 1.317
Città #
Fairfield 205
Chandler 136
Ashburn 110
Cambridge 62
Houston 60
Woodbridge 57
Seattle 52
Wilmington 48
Ann Arbor 38
San Diego 31
Singapore 26
Medford 19
Princeton 19
Bari 18
Padova 17
Dong Ket 14
Helsinki 11
Des Moines 8
Milan 7
Guangzhou 6
Roxbury 6
Treviso 6
Beijing 5
Lappeenranta 5
New York 5
Venice 5
Casoria 4
Jinan 4
London 4
Shanghai 4
Beltsville 3
Boardman 3
Gragnano 3
Midvale 3
Ogden 3
Ponte San Pietro 3
Rimini 3
Rome 3
Stockholm 3
Vicenza 3
Ahmedabad 2
Bitonto 2
Bologna 2
Catania 2
Cincinnati 2
Falkenstein 2
Ferrara 2
Ferristown 2
Genoa 2
Hebei 2
Hounslow 2
Hyderabad 2
Melbourne 2
Miami 2
Phoenix 2
Pianiga 2
Rovereto 2
Santa Giustina in Colle 2
Vedelago 2
Zurich 2
Atlanta 1
Bolzano 1
Bucharest 1
Chelyabinsk 1
Chennai 1
Chongqing 1
Dublin 1
Florissant 1
Gonnosnò 1
Haikou 1
Hefei 1
Kilburn 1
Ljubljana 1
Los Angeles 1
Marcallo con Casone 1
Nanchang 1
Nanjing 1
Nashville 1
Ningbo 1
Norwalk 1
Parma 1
Pisa 1
Portici 1
Prescot 1
Redwood City 1
Rockville 1
Shenyang 1
São Paulo 1
Tappahannock 1
Tours 1
Utrecht 1
Verona 1
Villafranca di Verona 1
Washington 1
Zhengzhou 1
Totale 1.097
Nome #
Adult-Onset Still’s Disease: Molecular Pathophysiology and Therapeutic Advances 142
Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease 113
SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients 97
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 84
Belimumab: a step forward in the treatment of systemic lupus erythematosus 81
Canakinumab for the treatment of adult-onset Still’s disease 68
Osteoporosis in Systemic Autoinflammatory Diseases: A Case-Control Study 68
POSSIBLE ADVANTAGES OF 18F-FDG PET/CT-MR IN ADULT-ONSET STILL’S DISEASE: A STUDY FROM AN ITALIAN COHORT 67
Autoinflammatory Features in Gouty Arthritis 66
The amount of cytokine-release defines different shades of Sars-Cov2 infection 59
Autoinflammatory Mechanisms in Crystal-Induced Arthritis 58
JAK inhibitors for the treatment of VEXAS syndrome 57
Sarcoidosis and Autoimmunity: From Genetic Background to Environmental Factors 55
18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography With Magnetic Resonance for Diagnosing Adult-Onset Still's Disease 54
Regulation of crystal induced inflammation: current understandings and clinical implications 50
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 44
The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities 33
New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort 29
A Pro-Inflammatory Signature Constitutively Activated in Monogenic Autoinflammatory Diseases 27
Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series 26
Pulmonary alveolar proteinosis in an adult patient affected by Still's disease and recurrent episodes of macrophage activation syndrome 22
Progress in Biological Therapies for Adult-Onset Still’s Disease 18
Hyperinflammation after anti-SARS-CoV-2 mRNA/DNA vaccines successfully treated with anakinra: Case series and literature review 13
IL-18 in Autoinflammatory Diseases: Focus on Adult Onset Still Disease and Macrophages Activation Syndrome 12
Autoinflammatory Diseases and COVID-19 Vaccination: Analysis of SARS-CoV-2 Anti-S-RBD IgG Levels in a Cohort of Patients Receiving IL-1 Inhibitors 7
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 6
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 5
THE ADVANTAGES OF NEXT GENERATION SEQUENCING FOR CORRECTLY DIAGNOSING RARE RHEUMATIC AUTOINFLAMMATORY DISEASES: A SINGLE-CENTER STUDY 4
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 3
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission 2
Fertility issues in women of childbearing age with spondyloarthritis 2
Totale 1.372
Categoria #
all - tutte 6.890
article - articoli 6.845
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.735


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020173 0 16 1 7 13 9 19 32 24 10 35 7
2020/2021275 11 20 14 9 5 10 4 18 25 36 30 93
2021/2022331 13 9 29 9 29 43 10 20 29 27 31 82
2022/2023248 57 32 13 25 26 15 3 14 24 4 35 0
2023/2024274 6 29 20 18 16 33 14 16 39 32 21 30
2024/20256 5 1 0 0 0 0 0 0 0 0 0 0
Totale 1.372